| Pfizer AG - Ruxience 500 mg/50 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 69701 | | 02 | | Ruxience 500 mg/50 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L01FA01 | | | | 19.08.2024 | | |
|
| Composition |
| rituximabum 500 mg, histidinum, histidini hydrochloridum monohydricum, dinatrii edetas corresp. natrium 0.35 mg, polysorbatum 80, saccharum, aqua ad iniectabile q.s. ad solutionem pro 50 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Rituximab | 500mg / 50ml |
| | BAG: Active Agent | Dose |
|---|
| Rituximab | 500 mg |
| | | | Inactive agents |
|---|
| Dinatrii Edetas | | Histidin Hydrochloride Monohydrate | | Histidine | | Polysorbatum 80 | | Saccharum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | | 1051.32 | 1159.80 | A | SL | No |
|
